These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 16054231

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Modulation of acute graft-versus-host disease and chimerism after adoptive transfer of in vitro-expanded invariant Valpha14 natural killer T cells.
    Kuwatani M, Ikarashi Y, Iizuka A, Kawakami C, Quinn G, Heike Y, Yoshida M, Asaka M, Takaue Y, Wakasugi H.
    Immunol Lett; 2006 Jul 15; 106(1):82-90. PubMed ID: 16806496
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by alpha-galactosylceramide in vivo.
    Chamoto K, Takeshima T, Kosaka A, Tsuji T, Matsuzaki J, Togashi Y, Ikeda H, Nishimura T.
    Immunol Lett; 2004 Aug 15; 95(1):5-11. PubMed ID: 15325792
    [Abstract] [Full Text] [Related]

  • 8. Effects of cyclosporin A on the activation of natural killer T cells induced by alpha-galactosylceramide.
    Kajiwara T, Tomita Y, Okano S, Iwai T, Yasunami Y, Yoshikai Y, Nomoto K, Yasui H, Tominaga R.
    Transplantation; 2007 Jan 27; 83(2):184-92. PubMed ID: 17264815
    [Abstract] [Full Text] [Related]

  • 9. Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity.
    Fujii S, Shimizu K, Hemmi H, Steinman RM.
    Immunol Rev; 2007 Dec 27; 220():183-98. PubMed ID: 17979847
    [Abstract] [Full Text] [Related]

  • 10. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.
    Sharif S, Arreaza GA, Zucker P, Mi QS, Sondhi J, Naidenko OV, Kronenberg M, Koezuka Y, Delovitch TL, Gombert JM, Leite-De-Moraes M, Gouarin C, Zhu R, Hameg A, Nakayama T, Taniguchi M, Lepault F, Lehuen A, Bach JF, Herbelin A.
    Nat Med; 2001 Sep 27; 7(9):1057-62. PubMed ID: 11533711
    [Abstract] [Full Text] [Related]

  • 11. Hyporesponsiveness to natural killer T-cell ligand alpha-galactosylceramide in cancer-bearing state mediated by CD11b+ Gr-1+ cells producing nitric oxide.
    Yanagisawa K, Exley MA, Jiang X, Ohkochi N, Taniguchi M, Seino K.
    Cancer Res; 2006 Dec 01; 66(23):11441-6. PubMed ID: 17145891
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-18 regulates T helper 1 or 2 immune responses of human cord blood CD4+ V alpha 24+V beta 11+ natural killer T cells.
    Fujibayashi Y, Fujimori Y, Kasumoto I, Kai S, Hara H, Okamura H, Tsutsui H, Ogawa H, Nakanishi K.
    Int J Mol Med; 2007 Aug 01; 20(2):241-5. PubMed ID: 17611643
    [Abstract] [Full Text] [Related]

  • 13. Polarization of natural killer T cells towards an NKT2 subpopulation occurs after stimulation with alpha-galactosylceramide and rhG-CSF in aplastic anemia.
    Wang Y, Hu X, Guo C, Zhang Q, Peng J, Zhang J, Li L, Zhang T, Xu C.
    Acta Haematol; 2008 Aug 01; 119(3):178-86. PubMed ID: 18535366
    [Abstract] [Full Text] [Related]

  • 14. In vitro anti-tumour activity of alpha-galactosylceramide-stimulated human invariant Valpha24+NKT cells against melanoma.
    Kikuchi A, Nieda M, Schmidt C, Koezuka Y, Ishihara S, Ishikawa Y, Tadokoro K, Durrant S, Boyd A, Juji T, Nicol A.
    Br J Cancer; 2001 Sep 01; 85(5):741-6. PubMed ID: 11531261
    [Abstract] [Full Text] [Related]

  • 15. Does the developmental status of Valpha14i NKT cells play a role in disease?
    Matsuda JL, Gapin L.
    Int Rev Immunol; 2007 Sep 01; 26(1-2):5-29. PubMed ID: 17454262
    [Abstract] [Full Text] [Related]

  • 16. Selective requirement for c-Myc at an early stage of V(alpha)14i NKT cell development.
    Mycko MP, Ferrero I, Wilson A, Jiang W, Bianchi T, Trumpp A, MacDonald HR.
    J Immunol; 2009 Apr 15; 182(8):4641-8. PubMed ID: 19342639
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.